COVID-19 and Cancer: Current Challenges and Perspectives
Top Cited Papers
- 1 October 2020
- journal article
- review article
- Published by Elsevier BV in Cancer Cell
- Vol. 38 (5), 629-646
- https://doi.org/10.1016/j.ccell.2020.09.018
Abstract
No abstract availableFunding Information
- Dana-Farber Cancer Institute
- Vanderbilt University
- Columbia University
This publication has 142 references indexed in Scilit:
- Thrombosis as an intravascular effector of innate immunityNature Reviews Immunology, 2012
- Infections in Patients With Hematologic Neoplasms and Hematopoietic Stem Cell Transplantation: Neutropenia, Humoral, and Splenic DefectsClinical Infectious Diseases, 2011
- Androgen receptor and androgen-dependent gene expression in lungMolecular and Cellular Endocrinology, 2010
- Immune surveillance of tumorsJCI Insight, 2007
- ACE2 of the heart: From angiotensin I to angiotensin (1–7)Cardiovascular Research, 2007
- Effect of Angiotensin-Converting Enzyme Inhibition and Angiotensin II Receptor Blockers on Cardiac Angiotensin-Converting Enzyme 2Journal of the American College of Cardiology, 2005
- An interferon‐γ‐related cytokine storm in SARS patientsJournal of Medical Virology, 2004
- Venous Thromboembolism and Cancer: Risks and OutcomesJournal of the American College of Cardiology, 2003
- Aspirin Alters the Cardioprotective Effects of the Factor XIII Val34Leu PolymorphismJournal of the American College of Cardiology, 2003
- Inflammation and cancerNature, 2002